Alison Crawford

Person

Dobbs Ferry, NY, US

People

Patents Grantslast 30 patents

Information Patent Grant
Use of bispecific antigen-binding molecules that bind MUC16 and CD3...
- Patent number 12,091,460
- Issue date Sep 17, 2024
- REGENERON PHARMACEUTICALS, INC.
- Jessica R. Kirshner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-STEAP2 antibodies, antibody-drug conjugates, and bispecific an...
- Patent number 11,633,501
- Issue date Apr 25, 2023
- REGENERON PHARMACEUTICALS, INC.
- John Rudge
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-MUC16 antibodies, antibody-drug conjugates, and bispecific ant...
- Patent number 11,485,793
- Issue date Nov 1, 2022
- REGENERON PHARMACEUTICALS, INC.
- Lauric Haber
- G01 - MEASURING TESTING
Information Patent Grant
Bispecific anti-MUC16 x anti-CD28 antibodies and uses thereof
- Patent number 11,453,721
- Issue date Sep 27, 2022
- Regeneran Pharmaceuticals, Inc.
- Andrew J. Murphy
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for treating cancer with bispecific anti-CD3xMUC16 antibodi...
- Patent number 11,254,752
- Issue date Feb 22, 2022
- REGENERON PHARMACEUTICALS, INC.
- Alison Crawford
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-PSMA antibodies, bispecific antigen-binding molecules that bin...
- Patent number 11,155,633
- Issue date Oct 26, 2021
- Regeneran Pharmaceuticals, Inc.
- Jessica R. Kirshner
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-MUC16 antibodies
- Patent number 10,941,208
- Issue date Mar 9, 2021
- REGENERON PHARMACEUTICALS, INC.
- Lauric Haber
- G01 - MEASURING TESTING
Information Patent Grant
Anti-STEAP2 antibody drug conjugates, and compositions and uses the...
- Patent number 10,772,972
- Issue date Sep 15, 2020
- REGENERON PHARMACEUTICALS, INC.
- John Rudge
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bispecific antigen-binding molecules that bind MUC16 and CD3, and c...
- Patent number 10,738,130
- Issue date Aug 11, 2020
- REGENERON PHARMACEUTICALS, INC.
- Lauric Haber
- G01 - MEASURING TESTING
Information Patent Grant
Anti-PSMA antibodies, bispecific antigen-binding molecules that bin...
- Patent number 10,179,819
- Issue date Jan 15, 2019
- REGENERON PHARMACEUTICALS, INC.
- Jessica R. Kirshner
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
Bispecific Anti-MUC16 x Anti-CD28 Antibodies and Uses Thereof
- Publication number 20230279113
- Publication date Sep 7, 2023
- Regeneron Pharmaceuticals, Inc.
- Andrew J. Murphy
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Anti-MUC16 Antibodies, Antibody-Drug Conjugates, and Bispecific Ant...
- Publication number 20230272111
- Publication date Aug 31, 2023
- Regeneron Pharmaceuticals, Inc.
- Lauric Haber
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Anti-PSMA Antibodies, Bispecific Antigen-Binding Molecules That Bin...
- Publication number 20210403595
- Publication date Dec 30, 2021
- Regeneron Pharmaceuticals, Inc.
- Jessica R. Kirshner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF BISPECIFIC ANTIGEN-BINDING MOLECULES THAT BIND MUC16 AND CD3...
- Publication number 20200399371
- Publication date Dec 24, 2020
- Regeneron Pharmaceuticals, Inc.
- Jessica R. Kirshner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF BISPECIFIC ANTIGEN-BINDING MOLECULES THAT BIND PSMA AND CD3...
- Publication number 20200399372
- Publication date Dec 24, 2020
- Regeneron Pharmaceuticals, Inc.
- Jessica R. Kirshner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Anti-STEAP2 Antibodies, Antibody-Drug Conjugates, and Bispecific An...
- Publication number 20200376136
- Publication date Dec 3, 2020
- Regeneron Pharmaceuticals, Inc.
- John Rudge
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Anti-MUC16 Antibodies, Antibody-Drug Conjugates, and Bispecific Ant...
- Publication number 20200317810
- Publication date Oct 8, 2020
- Regeneron Pharmaceuticals, Inc.
- Lauric Haber
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC ANTI-MUC16 X ANTI-CD28 ANTIBODIES AND USES THEREOF
- Publication number 20200199233
- Publication date Jun 25, 2020
- Regeneron Pharmaceuticals, Inc.
- Andrew J. Murphy
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Methods for Treating Cancer with Bispecific Anti-CD3xMUC16 Antibodi...
- Publication number 20190389966
- Publication date Dec 26, 2019
- Regeneron Pharmaceuticals, Inc.
- Alison Crawford
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Anti-PSMA Antibodies, Bispecific Antigen-Binding Molecules that Bin...
- Publication number 20190127480
- Publication date May 2, 2019
- Jessica R. Kirshner
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Anti-MUC16 Antibodies, Antibody-Drug Conjugates, and Bispecific Ant...
- Publication number 20180118848
- Publication date May 3, 2018
- Regeneron Pharmaceuticals, Inc.
- Lauric Haber
- G01 - MEASURING TESTING
Information Patent Application
Anti-MUC16 Antibodies, Antibody-Drug Conjugates, and Bispecific Ant...
- Publication number 20180112001
- Publication date Apr 26, 2018
- Regeneron Pharmaceuticals, Inc.
- Lauric Haber
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Anti-STEAP2 Antibodies, Antibody-Drug Conjugates, and Bispecific An...
- Publication number 20180104357
- Publication date Apr 19, 2018
- Regeneron Pharmaceuticals, Inc.
- John Rudge
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Anti-PSMA Antibodies, Bispecific Antigen-Binding Molecules that Bin...
- Publication number 20170051074
- Publication date Feb 23, 2017
- Regeneron Pharmaceuticals, Inc.
- Jessica R. Kirshner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Alison Crawford

Person

Patents Grantslast 30 patents

Use of bispecific antigen-binding molecules that bind MUC16 and CD3...

Anti-STEAP2 antibodies, antibody-drug conjugates, and bispecific an...

Anti-MUC16 antibodies, antibody-drug conjugates, and bispecific ant...

Bispecific anti-MUC16 x anti-CD28 antibodies and uses thereof

Methods for treating cancer with bispecific anti-CD3xMUC16 antibodi...

Anti-PSMA antibodies, bispecific antigen-binding molecules that bin...

Anti-MUC16 antibodies

Anti-STEAP2 antibody drug conjugates, and compositions and uses the...

Bispecific antigen-binding molecules that bind MUC16 and CD3, and c...

Anti-PSMA antibodies, bispecific antigen-binding molecules that bin...

Patents Applicationslast 30 patents

Bispecific Anti-MUC16 x Anti-CD28 Antibodies and Uses Thereof

Anti-MUC16 Antibodies, Antibody-Drug Conjugates, and Bispecific Ant...

Anti-PSMA Antibodies, Bispecific Antigen-Binding Molecules That Bin...

USE OF BISPECIFIC ANTIGEN-BINDING MOLECULES THAT BIND MUC16 AND CD3...

USE OF BISPECIFIC ANTIGEN-BINDING MOLECULES THAT BIND PSMA AND CD3...

Anti-STEAP2 Antibodies, Antibody-Drug Conjugates, and Bispecific An...

Anti-MUC16 Antibodies, Antibody-Drug Conjugates, and Bispecific Ant...

BISPECIFIC ANTI-MUC16 X ANTI-CD28 ANTIBODIES AND USES THEREOF

Methods for Treating Cancer with Bispecific Anti-CD3xMUC16 Antibodi...

Anti-PSMA Antibodies, Bispecific Antigen-Binding Molecules that Bin...

Anti-MUC16 Antibodies, Antibody-Drug Conjugates, and Bispecific Ant...

Anti-MUC16 Antibodies, Antibody-Drug Conjugates, and Bispecific Ant...

Anti-STEAP2 Antibodies, Antibody-Drug Conjugates, and Bispecific An...

Anti-PSMA Antibodies, Bispecific Antigen-Binding Molecules that Bin...